loader

Disclaimer

The Bar Council of India does not permit advertisement or solicitation by advocates in any form or manner. By accessing this website, www.khaitanco.com, you acknowledge and confirm that you are seeking information relating to Khaitan & Co of your own accord and that there has been no form of solicitation, advertisement or inducement by Khaitan & Co or its members. The content of this website is for informational purposes only and should not be interpreted as soliciting or advertisement. No material/information provided on this website should be construed as legal advice. Khaitan & Co shall not be liable for consequences of any action taken by relying on the material/information provided on this website. The contents of this website are the intellectual property of Khaitan & Co.

Please accept the above
Close

Search

See all results for ""

Firm Matters

Bridgepoint Group’s proposed acquisition of GBA Group from Ardian

  • 20-Jul-2026

Khaitan & Co advised Bridgepoint Group on the India aspects of its proposed acquisition of a majority stake in GBA Group from Ardian.

GBA Group is a leading provider of specialist laboratory testing services and operates at around 100 locations across Europe, North America, Asia-Pacific and other international markets. In India, GBA Group operates through Eureka Analytical Services Private Limited and Teena Bio Labs Pvt Ltd.

About Bridgepoint Group:  

Bridgepoint Group is one of the world's leading mid-market investors, specialising in private equity, infrastructure, credit, secondaries and private wealth. With $98 billion of assets under management and a strong local presence in Europe, North America and Asia, we combine global scale with local market insight and sector expertise, consistently delivering strong returns through cycles.

In June 2026, Bridgepoint Group announced the acquisition of Kayne Anderson Real Estate, adding real estate as a fifth investment vertical and expanding the firm's presence in the United States. Following completion, anticipated at the end of 2026 subject to customary shareholder and regulatory approvals and fund consents, the transaction is expected to increase the Group's combined AUM to $117 billion.

About GBA Group:

GBA Group is a leading international life sciences services provider specialising in laboratory testing, analytical, logistical and consulting services. Headquartered in Hamburg, Germany, the company operates a global network of laboratories serving more than 60,000 customers across the environmental, food, pharmaceutical, chemicals, medical devices and cosmetics sectors.

Deal Team

Bridgepoint

The core team from consisted of Anshuman Mozumdar (Partner), Aditi Halder (Senior Associate), Amogh Pareek (Senior Associate), Nikhil Tadikonda (Senior Associate), Akshat Shukla (Associate) and Ranjul Malik (Associate)

Strategic Guidance

The deal was assisted by:

Employment, Labour & Benefits: Deepak Kumar (Partner) and Varsha Sankara Raman (Senior Associate)

Intellectual Property: Sourav Dan (Counsel) and Shouraseni Chakraborty (Associate)

Dispute Resolution: Swati Singh (Principal Associate)